Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_assertion type Assertion NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_head.
- NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_provenance.
- NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_assertion evidence source_evidence_literature NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_provenance.
- NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_assertion SIO_000772 15535838 NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_provenance.
- NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_assertion wasDerivedFrom befree-2016 NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_provenance.
- NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_assertion wasGeneratedBy ECO_0000203 NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_provenance.